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Background: The purpose of this study was to assess the histological changes 
occurring in the vagina and vulva in ovariectomised female rats, as well as the 
response to the administration of injectable oestrogens. 
Material and methods: We used 30 female Wistar white rats, distributed as 
follows: group 1 — the control group, group 2 — the operated but untreated 
rats, and groups 3, 4 and 5 — operated rats, to which oestrogenic treatment was 
administered (Estradiol, Estradurin, Sintofolin) at a dosage of 0.2 mg/rat/day. After 
14 days of treatment, all animals were sacrificed and vaginal and vulvar biopsies 
were taken from all groups. 
Results: In group 2, we encountered structural changes of the vaginal mucosa, 
with severe atrophy and alterations in the thickness of the vagina and vulva. In 
groups 3, 4 and 5 we found marked hyperplasia of the vaginal and vulvar epit-
helium, eosinophilic and mast cell infiltration in the chorion. 
Conclusions: Our study proves that the histopathological changes during ano-
estrus after administration of oestrogens are cell hyperplasia, thickening of the 
superficial mucosal layer, eosinophilic and mast cells infiltrations, and chorionic 
congestion. Furthermore, we demonstrated that Estradiol therapy induces the 
most evident histological changes when compared to synthetic oestrogens such 
as Estradurin or Sintofolin. (Folia Morphol 2016; 74, 4: 467–473)
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INTRODUCTION
General and local modifications appear during 
menopause as a response to the deficiency in oes-
trogens, which may occur progressively in natural 
menopause, or suddenly in surgical menopause [11, 
24]. Such morphological and structural modifications 
are often associated with alterations in various organs, 
thus influencing the quality of life [10, 23].
Over the last years, there has been some controversy 
over hormone replacement therapy, due to its various 
side effects, such as breast, endometrial and ovarian 
cancer, cerebrovascular accident, or thromboembolic 
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disease [7, 20, 25]. These risks can be avoided through 
correct monitoring, mammography and echography 
with measurement of endometrial thickness [3].
A decrease in hormonal activity can be experimen-
tally created through bilateral ovariectomy in female 
rats [17]. The ovariectomy in the rat induces perma-
nent anoestrus, but it is not similar to the human 
physiological menopause. This experimental model 
plays an important role in understanding the patho-
physiological modifications of the anoestrus syndrome, 
thus helping in the development of multiple adjuvant 
therapies [5, 12].
It is known that the action of oestrogens is exerted 
through receptors in the genital tract, the mammary 
gland and the nervous system [26].
Oestrogens have an important regulating effect on 
cell proliferation, a function that is mediated by the 
alpha (ER-a) and beta (ER-b) oestrogenic receptors [9]. 
Under normal conditions, ER-a receptors are expressed 
in the adenohypophysis, breast, uterus, uterine tract 
and vagina, while ER-b receptors are expressed in the 
urinary tract, ovary, thyroid, skin, lung and thymus [18, 
33]. Due to the large number of oestrogenic receptors in 
the vagina and vulva, the latter will react promptly to the 
action of oestrogens, both natural and synthetic [1, 2, 8].
This experimental study aims to assess the histo-
logical modifications occurring in the vagina and vulva 
of ovariectomised female rats, as well as the response 
to the administration of injectable oestrogens.
MaTeRIalS aND MeTHODS
This study was conducted using a total of 30 female 
Wistar white rats, with an average weight of 200 g, 
obtained from the laboratory animal facility of the 
“Iuliu Hatieganu” University of Medicine and Pharmacy 
of Cluj-Napoca. Throughout the experiment, the rats 
were given standard food and water ad libitum, thus 
observing the standard conditions required by the cur-
rent legislation on the protection of laboratory animals. 
The following study groups were created:
 — Group 1 — control group (no surgical interven-
tion, no oestrogenic treatment, pre anoestrus), 
including 5 subjects;
 — Group 2 — operated, anoestrus, without treat-
ment — 5 subjects;
 — Group 3 — operated and treated with Estradiol (i.e. 
a natural oestrogen, at a dosage of 0.2 mg/day/rat, 
for a period of 14 days) — 6 subjects;
 — Group 4 — operated and treated with Estradurin 
(i.e. a synthetic oestrogen, at a dosage of 0.2 mg/ 
/rat, every 7 days, for a period of 14 days) — 
7 subjects;
 — Group 5 — operated and treated with Sintofolin 
(i.e. a synthetic oestrogen, at a dosage of 0.2 mg/ 
/day/rat, for a period of 14 days) — 7 subjects.
Bilateral ovariectomy was performed in 25 of the 
30 female rats included in the study. The ovariectomy 
was performed in accordance with the technique de-
scribed by Nevalainen et al. [22]. The animals were 
anesthetized by intramuscular injection of a mixture 
of Xylasine (10 mg/kg, Xylocontact) and ketamine 
(100 mg/kg). The neuroleptanalgesia was induced for 
a period of 30–90 min, time needed for the surgical 
intervention. Under sterile conditions, a 2–3 cm ventral 
midline incision was made into the skin and muscle 
wall of the upper abdomen (to expose the ovaries). 
After permanent haemostasis, the ovaries were re-
moved and the skin was closed with interrupted 3-0 
silk sutures. The anoestrus phase was considered to 
be installed 15 days after surgery. To confirm this, the 
oestradiol level was tested 15 days after surgery, in 
order to compare oestradiol hormonal levels pre and 
post-surgery. 
Once the anoestrus was confirmed in all study 
groups, we began administering various injectable 
oestrogen hormonal formulas, over a 14-day period.
Estradiol (Biofarm, Bucharest, Romania, Zip code: 
031212) was used for group 3; each 1 mL-vial of 
injectable oily liquid contained 2.5 mg oestradiol, 
which was diluted in 9 mL neutralised and sterilised 
sunflower oil, so that for a dose 0.2 mg of oestradiol/ 
/rat/day, we administered 0.8 mL of oily solution. Estra-
durin (Pharmacia & Upjohn Company LLC [a subsidiary 
of Pfizer Inc.]), 7000 Portage Road Kalamazoo, MI 
49001 United States, is a synthetic oestrogen which 
was used for group 4; each 2 mL-vial contained 80 mg 
of powdered polyoestradiol phosphate, diluted in 
38 mL of distilled water, so that for 0.2 mg of oestradiol/ 
/rat/day, we administered 0.1 mL solution. Estradurin 
was administered at 7-day intervals since it is a pow-
erful phosphatase inhibitor, with a particularly slow 
release, ensuring considerable oestrogenic activity 
for a prolonged period of time, even weeks after 
the injection. Sintofolin (Terapia S.A, 400632, Cluj-
Napoca, jud. Cluj, Romania), a synthetic oestrogen, 
was used for group 5; each 2 mL vial of injectable oily 
liquid contained 5 mg of hexoestrol diacetate, which 
was diluted with 8 mL of neutralised and sterilised 
sunflower oil, so that 0.4 mL of oily solution was 
administered for 0.2 mg/rat/day.
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For the histopathological examination, biopsies 
from the vaginal mucosa and vulva were placed in 
10% neutral buffered formalin, included in paraffin, 
and 4 micrometre sections were cut with a Leica 
RM 2125 RT microtome. The sections were stained 
with the haematoxylin-eosin (HE) method. They were 
examined with an Olympus BX 51 microscope; the 
images were taken with an Olympus DP 25 digital 
camera, and then edited with the help of the Olympus 
Cell B application.
Statistical analysis
We first performed a descriptive analysis of the 
variables, at both the parametric (using means and 
standard deviations) and the graphic levels. Since all 
variables are quantitative (scales), we assessed the 
At the end of the study, 14 days after treatment, all 
the animals were sacrificed using the cervical disloca-
tion method. Vaginal and vulvar biopsies were taken 
from all groups, and the samples were subjected to 
a histopathological examination, so as to obtain the 
necessary results and data for attaining the objective 
of this experimental study.
Vaginal and vulvar biopsies were taken from all 
groups and the samples were examined by a patholo-
gist from the Department of Veterinary Toxicology of 
the University of Agricultural Sciences and Veterinary 
Medicine, Cluj-Napoca.  
The protocol used in this experimental study was 
approved by the Ethics Committee of the “Iuliu Hatie-
ganu” University of Medicine and Pharmacy of Cluj-
Napoca (approval no. 116/06.03.2015).
Table 1. Weight of the rats/day
Group (Gr);  
subject (S)
Body weight
Day  
1
Day  
2
Day  
3
Day  
4
Day  
5
Day  
6
Day  
7
Day  
8
Day  
9
Day 
10
Day 
11
Day 
12
Day 
13
Day 
14
Gr 2; S6 235 g 230 g 233 g 235 g 238 g 243 g 240 g 240 g 240 g 239 g 239 g 238 g 242 g 242 g
Gr 2; S7 225 g 225 g 221 g 223 g 220 g 242 g 238 g 240 g 241 g 239 g 240 g 241 g 242 g 238 g
Gr 2; S8 210 g 215 g 237 g 230 g 237 g 232 g 222 g 225 g 226 g 225 g 224 g 222 g 225 g 225 g
Gr 2; S9 250 g 250 g 256 g 254 g 256 g 263 g 260 g 255 g 255 g 258 g 256 g 257 g 256 g 259 g
Gr 2; S10 225 g 225 g 224 g 222 g 228 g 229 g 227 g 225 g 226 g 225 g 225 g 226 g 227 g 226 g
Gr 3; S11 233 g 230 g 193 g 200 g 194 g 196 g 194 g 220 g 218 g 222 g 220 g 220 g 222 g 221 g
Gr 3; S12 206 g 210 g 211 g 208 g 206 g 205 g 208 g 210 g 212 g 215 g 210 g 212 g 210 g 210 g
Gr 3; S13 250 g 250 g 247 g 245 g 242 g 246 g 244 g 248 g 243 g 240 g 245 g 242 g 240 g 242 g
Gr 3; S14 215 g 215 g 215 g 211 g 210 g 218 g 218 g 215 g 218 g 218 g 215 g 215 g 215 g 219 g
Gr 3; S15 260 g 225 g 211 g 210 g 216 g 213 g 213 g 215 g 215 g 213 g 217 g 218 g 215 g 212 g
Gr 3; S16 225 g 230 g 236 g 233 g 230 g 228 g 223 g 223 g 220 g 225 g 225 g 222 g 225 g 228 g
Gr 4; S17 230 g 210 g 195 g 195 g 194 g 196 g 192 g 195 g 195 g 198 g 196 g 197 g 195 g 196 g
Gr 4; S18 225 g 200 g 207 g 208 g 210 g 206 g 205 g 205 g 208 g 207 g 207 g 208 g 205 g 208 g
Gr 4; S19 230 g 225 g 240 g 225 g 216 g 218 g 213 g 215 g 216 g 215 g 217 g 215 g 214 g 216 g
Gr 4; S20 230 g 215 g 198 g 210 g 217 g 214 g 212 g 215 g 215 g 218 g 217 g 215 g 218 g 216 g
Gr 4; S21 200 g 205 g 226 g 225 g 227 g 226 g 226 g 226 g 225 g 226 g 225 g 227 g 226 g 225 g
Gr 4; S22 220 g 221 g 226 g 227 g 228 g 224 g 221 g 225 g 224 g 229 g 225 g 225 g 224 g 223 g
Gr 4; S23 220 g 225 g 240 g 238 g 236 g 234 g 220 g 227 g 228 g 230 g 228 g 227 g 228 g 229 g
Gr 5; S24 210 g 205 g 215 g 213 g 212 g 220 g 209 g 210 g 211 g 212 g 210 g 212 g 213 g 212 g
Gr 5; S25 200 g 200 g 187 g 186 g 186 g 186 g 183 g 185 g 186 g 187 g 185 g 183 g 186 g 185 g
Gr 5; S26 225 g 240 g 241 g 240 g 244 g 242 g 245 g 243 g 242 g 244 g 245 g 245 g 243 g 244 g
Gr 5; S27 240 g 230 g 212 g 210 g 212 g 214 g 209 g 210 g 211 g 210 g 212 g 211 g 212 g 212 g
Gr 5; S28 262 g 220 g 215 g 210 g 212 g 211 g 211 g 212 g 211 g 213 g 215 g 212 g 211 g 214 g
Gr 5; S29 260 g 210 g 214 g 212 g 213 g 214 g 209 g 210 g 215 g 212 g 210 g 214 g 210 g 212 g
Gr 5; S30 200 g 200 g 213 g 205 g 202 g 204 g 201 g 200 g 200 g 202 g 203 g 204 g 203 g 202 g
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concluded that the type of treatment has a significant 
influence on the thickness of the vulva (Fig. 4).
Atrophy of the vulva and vagina was calculated 
using 3-point morphometric measurements; this 
method insured a real morphological quantification 
and found statistically significant differences between 
groups.
Furthermore, during the study, we assessed the 
structural changes of the vagina and vulva on the 
biopsy samples. Apart from the changes in the di-
ameter of uterine horns found in the oestrogenic 
treatment groups, no macroscopic lesions were 
clearly noticeable during necropsy. The sections 
in the vaginal epithelium in group 1 (the control 
group) exhibited a normal morphology. The subjects 
in group 2 had a mild congestion of the submucosa, 
normality of their distribution, in order to establish 
the type of tests to be applied (parametric or non-
parametric). The final decision was taken on the basis 
of the Shapiro-Wilk test.
The variation in corporal mass was studied on the 
sample of 25 operated rats. Since we measured the 
same individuals repeatedly, we performed the Re-
peated Measures type of multivariate analysis of vari-
ance (MANOVA). 
We compared the pre- and post-surgery Estradiol 
values using the Paired Samples Student (t) test.
The comparison of the thickness of the vagina and 
vulva, among the five study groups, was performed us-
ing the ANOVA method (analysis of variance in a simple 
format). The standard level of significance considered 
was 5%, but when the results were significant at 1% 
level, this was clearly stated.
ReSUlTS
During the study, we recorded variations of the 
body mass of each subject, leading to statistically 
significant differences among the groups, such as an 
increase in weight in group 2 rats and a decrease in 
weight in groups 3, 4 and 5 (Table 1, Fig. 1).
Surgically-induced anoestrus was demonstrated 
by determining post-surgery oestradiol levels, which 
were significantly different between the study groups 
(p = 0.000 < 0.01) (Fig. 2).
There were statistically significant differences in 
thickness of the vaginal epithelium between the groups 
treated with injectable oestrogens, (p = 0.000 < 0.05), 
proving that the type of treatment has a significant 
influence on the thickness of the vagina (Fig. 3).
There were statistically significant differences in 
thickness of the vulva between the groups treated with 
injectable oestrogens (p = 0.000 < 0.05). We therefore 
Figure 2. Comparison of pre/post-surgery oestradiol values.
Figure 1. Variation of weight depending on treatment.
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with eosinophils and mast cells in the chorion and 
submucosa and marked atrophy in the epithelium. 
Subjects in groups 3, 4 and 5, treated with various 
oestrogenic substances, exhibited marked vaginal 
hyperplasia, with an abundance of eosinophils and 
sporadic mast cells in the chorion. With regard to the 
vulva, group 1 was found to have a normal histologi-
cal structure, while group 2 exhibited severe atrophy 
of the mucosa. The subjects in groups 3, 4 and 5, 
which received treatment, presented various degrees 
of epithelial hyperplasia, and sometimes islands of 
hyperkeratosis (Fig. 5).
DISCUSSIONS
The experimental model of hormone replacement 
therapy, associated with surgically-induced anoestrus 
through bilateral ovariectomy in female rats, is well-
known [16, 28, 31].
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Figure 3. Differences in thickness of vaginal epithelium.
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Figure 4. Differences in thickness of vulva.
Figure 5. Effects of oestrogenic replacement therapy on vaginal (A, B, C, D, E, F, G) and valvular (H, I, J, K) morphology. Control group (A) 
showing normal histology; ME group, vaginal epithelial atrophy (B); Oestrogen replacement therapy submitted animals exhibited marked epi-
thelial hyperplasia, characterised by an increased number of cellular layers and thickness (C, D, E, F, G); Vulvar epithelial atrophy (I), normal 
female preputial gland histology (H) — ME group; Marked vulvar epithelial hyperplasia (K) and female preputial gland hyperplasia and hyper-
secretion (J), haematoxylin-eosin ×200, scale bar = 100 µm.
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In accordance with the validated animal model, the 
histopathological analysis in group 2 found evident 
atrophy in the epithelium, chorion and glandular tis-
sues of the vagina and vulva. This atrophy is associated 
with the absence of epithelial cornification, which are 
typical changes found in surgically-induced anoestrus 
in female rats. It is known that the cornification of the 
vaginal epithelium is a hormone-dependent phenom-
enon; some studies in literature report the presence 
of cornification in the absence of internal oestrogenic 
secretion in rats treated with oestrogens after birth 
[13, 15, 30]. In the groups treated with injectable 
oestrogens (Estradiol, Estradurin, Sintofolin), we found 
a marked presence of cell hyperplasia, along with 
a rich eosinophilic infiltration in the chorion and mast 
cell infiltration.
In this experimental study, Estradiol had the strong-
est effect on the proliferation of vaginal and vulvar 
epithelium, while Sintofolin had the weakest effect. 
Of the synthetic oestrogens, the Estradurin therapy 
yielded the strongest effect.
The response to injectable oestrogen treatment 
is fast and is due to the presence of a large number 
of oestrogenic receptors, either ER-a, or ER-b, in the 
genital and mammary system [19, 27].
We found that all three types of oestrogens used 
treated vaginal and vulvar atrophy.
Our study proves that treatment with injectable 
oestrogens for 14 consecutive days triggers vaginal 
and vulvar hyperplasia, as well as the improvement of 
structural modifications exhibited in ovariectomised 
female rats, in keeping with the findings of Kangas et 
al. [14] or Basha et al. [4].
The application in medical practice of our results 
is an argument for using oestrogenic substances in 
hormone replacement therapy [6, 21].
The morphological modifications occurring during 
menopause, due to the typical oestrogen deficiency, 
benefit from a considerable number of treatments and 
therapies, which are, however, often controversial with 
regard to the benefits, risks and side effects [29, 32].
CONClUSIONS
The vulvar and vaginal manifestations of the 
anoestrus phase are a direct response to the oestro-
gen deficiency. These changes are even more con-
spicuous when they occur suddenly, after a bilateral 
ovariectomy. Moreover, we have demonstrated that 
the Estradiol therapy induces the most evident his-
tological modifications, compared to Estradurin or 
Sintofolin. Estradiol was proven to be the most ef-
fective in treating the alterations occurring during 
surgically-induced anoestrus, while of the synthetic 
oestrogens, Estradurin had the strongest effect.
All three types of oestrogens, administered via in-
jection over a period of 14 days, led to the involution 
of atrophy by inducing vaginal and vulvar hyperplasia, 
as well as the improvement in structural modifica-
tions appearing in female rats as a consequence of 
surgery-induced anoestrus.
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